The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention

[1]  S. Kittel-Schneider,et al.  Lithium-induced gene expression alterations in two peripheral cell models of bipolar disorder , 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[2]  L. Yatham,et al.  Biomarkers in mood disorders: Are we there yet? , 2018, Journal of affective disorders.

[3]  Sara B. Linker,et al.  Prediction of response to drug therapy in psychiatric disorders , 2018, Open Biology.

[4]  R. Machado-Vieira.  Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator. , 2017, Journal of affective disorders.

[5]  Yong-Ku Kim,et al.  An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms , 2017, International journal of molecular sciences.

[6]  M. Alda.  Who are excellent lithium responders and why do they matter? , 2017, World psychiatry : official journal of the World Psychiatric Association.

[7]  M. Trivedi,et al.  Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks. , 2017, Journal of affective disorders.

[8]  A. Young,et al.  Biomarkers for depression: recent insights, current challenges and future prospects , 2017, Neuropsychiatric disease and treatment.

[9]  M. Leboyer,et al.  Clinical factors associated with lithium response in bipolar disorders , 2017, The Australian and New Zealand journal of psychiatry.

[10]  N. Veronese,et al.  Does the “Silver Bullet” Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients , 2016, Clinical practice and epidemiology in mental health : CP & EMH.

[11]  B. Frey,et al.  Update on bipolar disorder biomarker candidates , 2016, Expert review of molecular diagnostics.

[12]  Ather Muneer,et al.  Staging Models in Bipolar Disorder: A Systematic Review of the Literature , 2016, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[13]  J. Soares,et al.  A Selective Association between Central and Peripheral Lithium Levels in Remitters in Bipolar Depression: A 3T‐7Li Magnetic Resonance Spectroscopy Study , 2016, Acta psychiatrica Scandinavica.

[14]  Janice M. Fullerton,et al.  Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study , 2016, The Lancet.

[15]  S. Strakowski,et al.  First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine , 2015, Psychiatry Research.

[16]  S. Marie,et al.  Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder , 2015, European Neuropsychopharmacology.

[17]  Chen Zhang,et al.  IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode. , 2015, Journal of affective disorders.

[18]  Tiffany M. Chaim,et al.  Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes. , 2015, Journal of psychiatric research.

[19]  Moon-Soo Lee,et al.  Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: a commentary. , 2015, Bipolar disorders.

[20]  G. Busatto,et al.  Bimodal Effect of Lithium Plasma Levels on Hippocampal Glutamate Concentrations in Bipolar II Depression: A Pilot Study , 2015, The international journal of neuropsychopharmacology.

[21]  Tiffany M. Chaim,et al.  Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium , 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  M. Kunz,et al.  Biomarkers and staging of bipolar disorder: a systematic review. , 2014, Trends in psychiatry and psychotherapy.

[23]  M. Frye,et al.  Every reason to discontinue lithium , 2014, International Journal of Bipolar Disorders.

[24]  C. Zarate,et al.  Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodes. , 2014, Journal of psychiatric research.

[25]  K. Ikeda,et al.  Haplotype Analysis of GSK-3β Gene Polymorphisms in Bipolar Disorder Lithium Responders and Nonresponders , 2014, Clinical neuropharmacology.

[26]  M. Zanetti,et al.  Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder , 2014, European Neuropsychopharmacology.

[27]  G. Busatto,et al.  Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes , 2014, Psychopharmacology.

[28]  F. Ciregia,et al.  Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach. , 2014, Molecular bioSystems.

[29]  F. Bellivier,et al.  Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response , 2014, International Journal of Bipolar Disorders.

[30]  A. Carvalho,et al.  Lithium Decreases Plasma Adiponectin Levels in Bipolar Depression , 2014, Neuroscience Letters.

[31]  O. Forlenza,et al.  Lithium safety and tolerability in mood disorders: a critical review , 2014 .

[32]  C. Zarate,et al.  Oxidative stress in early stage Bipolar Disorder and the association with response to lithium. , 2014, Journal of psychiatric research.

[33]  J. Wakefield.  Wittgenstein's nightmare: why the RDoC grid needs a conceptual dimension , 2014, World psychiatry : official journal of the World Psychiatric Association.

[34]  T. Su,et al.  Variant GADL1 and response to lithium therapy in bipolar I disorder. , 2014, The New England journal of medicine.

[35]  S. Shinjo,et al.  Leukocyte mitochondrial DNA copy number in bipolar disorder , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[36]  J. Calabrese,et al.  Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS) , 2013, The Pharmacogenomics Journal.

[37]  M. Schalling,et al.  Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres , 2013, Translational Psychiatry.

[38]  D. Kupfer,et al.  Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value , 2013, British Journal of Psychiatry.

[39]  H. Möller,et al.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[40]  M. Leboyer,et al.  Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force , 2013, The Australian and New Zealand journal of psychiatry.

[41]  P. Das,et al.  Potential Mechanisms of Action of Lithium in Bipolar Disorder , 2013, CNS Drugs.

[42]  F. Kapczinski,et al.  Staging and Neuroprogression in Bipolar Disorder , 2012, Current Psychiatry Reports.

[43]  George P Patrinos,et al.  Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder. , 2011, Pharmacogenomics.

[44]  M. Tohen,et al.  Factors modifying drug and placebo responses in randomized trials for bipolar mania. , 2011, The international journal of neuropsychopharmacology.

[45]  O. Forlenza,et al.  Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study , 2011, Neuroscience Letters.

[46]  Pamela B. Mahon,et al.  Predictors of lithium response in bipolar disorder , 2011, Therapeutic advances in chronic disease.

[47]  R. Perlis.  Betting on biomarkers. , 2011, The American journal of psychiatry.

[48]  Flávio Kapczinski,et al.  Peripheral biomarkers and illness activity in bipolar disorder. , 2011, Journal of psychiatric research.

[49]  E. Vieta,et al.  Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder , 2011, Psychopharmacology.

[50]  J. Kelsoe,et al.  Pharmacogenetics of lithium response in bipolar disorder. , 2010, Pharmacogenomics.

[51]  Gangchun Wang,et al.  Regulation of glycogen synthase kinase-3 during bipolar mania treatment. , 2010, Bipolar disorders.

[52]  B. McEwen,et al.  Allostatic load biomarkers of chronic stress and impact on health and cognition , 2010, Neuroscience & Biobehavioral Reviews.

[53]  H. Kölsch,et al.  Reporting bias in medical research - a narrative review , 2010, Trials.

[54]  M. Alda,et al.  Early stages in the development of bipolar disorder. , 2010, Journal of affective disorders.

[55]  H. Möller,et al.  Principle standards and problems regarding proof of efficacy in clinical psychopharmacology , 2010, European Archives of Psychiatry and Clinical Neuroscience.

[56]  Alessio Squassina,et al.  Interacting genes in lithium prophylaxis: Preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients , 2009, Neuroscience Letters.

[57]  K. Evers,et al.  Personalized medicine in psychiatry: ethical challenges and opportunities , 2009, Dialogues in clinical neuroscience.

[58]  J. Calabrese,et al.  Lithium treatment — moderate dose use study (LiTMUS) for bipolar disorder: rationale and design , 2009, Clinical trials.

[59]  J. Calabrese,et al.  The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. , 2009, Bipolar disorders.

[60]  B. Frey,et al.  Clinical implications of a staging model for bipolar disorders , 2009, Expert review of neurotherapeutics.

[61]  J. Calabrese,et al.  Depressive relapse during lithium treatment associated with increased serum thyroid‐stimulating hormone: results from two placebo‐controlled bipolar I maintenance studies , 2009, Acta psychiatrica Scandinavica.

[62]  S. Purcell,et al.  A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. , 2009, The American journal of psychiatry.

[63]  L. Backlund,et al.  Identifying predictors for good lithium response – A retrospective analysis of 100 patients with bipolar disorder using a life-charting method , 2009, European Psychiatry.

[64]  M. Alda,et al.  Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features. , 2008, The Journal of clinical psychiatry.

[65]  M. Alda,et al.  Lithium response and genetic variation in the CREB family of genes , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[66]  M. Zompo,et al.  The PDLIM5 gene and lithium prophylaxis: an association and gene expression analysis in Sardinian patients with bipolar disorder. , 2008, Pharmacological research.

[67]  E. Vieta,et al.  Increasing rates of placebo response over time in mania studies. , 2008, The Journal of clinical psychiatry.

[68]  M. Phillips,et al.  Neuroimaging in bipolar disorder: A critical review of current findings , 2007, Current psychiatry reports.

[69]  Michael Berk,et al.  Setting the stage: from prodrome to treatment resistance in bipolar disorder. , 2007, Bipolar disorders.

[70]  H. Gurling,et al.  A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder , 2007, Pharmacogenetics and genomics.

[71]  J. Calabrese,et al.  Acute treatment of mania: An update on new medications , 2006, Current psychiatry reports.

[72]  I. Hickie,et al.  Clinical Staging of Psychiatric Disorders: A Heuristic Framework for Choosing Earlier, Safer and more Effective Interventions , 2006, The Australian and New Zealand journal of psychiatry.

[73]  N. Kleindienst,et al.  Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders. , 2005, Bipolar disorders.

[74]  P. Alderson,et al.  Absence of evidence is not evidence of absence , 2004, BMJ : British Medical Journal.

[75]  B. McEwen,et al.  Interacting mediators of allostasis and allostatic load: towards an understanding of resilience in aging. , 2003, Metabolism: clinical and experimental.

[76]  J. Calabrese,et al.  A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. , 2003, The Journal of clinical psychiatry.

[77]  M. Alda,et al.  Is response to prophylactic lithium a familial trait? , 2002, The Journal of clinical psychiatry.

[78]  R. Baldessarini,et al.  Lower suicide risk with long‐term lithium treatment in major affective illness:
a meta‐analysis , 2001, Acta psychiatrica Scandinavica.

[79]  Janet A Butler, David Taylor.  A survey of lithium monitoring and prescribing patterns , 2000, International journal of psychiatry in clinical practice.

[80]  M. Frye,et al.  Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients. , 1999, The American journal of psychiatry.

[81]  N. Turan,et al.  Predictors of lithium prophylaxis in bipolar patients. , 1999, Journal of affective disorders.

[82]  N. Black,et al.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.

[83]  Bruce Mcewen,et al.  Stress, Adaptation, and Disease: Allostasis and Allostatic Load , 1998, Annals of the New York Academy of Sciences.

[84]  F. Engelsmann,et al.  Predictors of Lithium Treatment Responsiveness in Bipolar Patients , 1998, Neuropsychobiology.

[85]  T. Inubushi,et al.  Relationship of lithium concentrations in the brain measured by lithium-7 magnetic resonance spectroscopy to treatment response in mania. , 1994, Journal of clinical psychopharmacology.

[86]  P. Vestergaard,et al.  Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. , 1990, Journal of affective disorders.

[87]  A. Coppen,et al.  Lithium therapy: from clinical trials to practical management , 1988, Acta psychiatrica Scandinavica.

[88]  W. Greil,et al.  Sequence of affective polarity and lithium response: Preliminary report on munich sample , 1987, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[89]  E. Robins,et al.  Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. , 1987, Archives of general psychiatry.

[90]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.

[91]  P. Baastrup,et al.  Lithium As a Prophylactic Agent: Its Effect Against Recurrent Depressions and Manic-Depressive Psychosis , 1967 .

[92]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[93]  T. Insel,et al.  Wesleyan University From the SelectedWorks of Charles A . Sanislow , Ph . D . 2010 Research Domain Criteria ( RDoC ) : Toward a New Classification Framework for Research on Mental Disorders , 2018 .

[94]  F. Bellivier,et al.  Lithium Response Variability: New Avenues and Hypotheses , 2017 .

[95]  J. Houenou,et al.  Neuroimaging and Lithium , 2017 .